Protein Sequencing - Global Strategic Business Report

Global Protein Sequencing Market to Reach $1.4 Billion by 2030

The global market for Protein Sequencing estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$1.4 Billion by 2030, growing at a CAGR of 0% over the analysis period 2022-2030. Mass Spectrometry, one of the segments analyzed in the report, is projected to record -0.2% CAGR and reach US$879.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Edman Degradation segment is readjusted to a revised 0.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $404.1 Million, While China is Forecast to Grow at -0.2% CAGR

The Protein Sequencing market in the U.S. is estimated at US$404.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$244.9 Million by the year 2030 trailing a CAGR of -0.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -0.5% and -0.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 0% CAGR.

Select Competitors (Total 34 Featured) -

• Agilent Technologies
• Bioinformatics Solution
• Charles River Laboratories
• Proteome Factory
• Rapid Novor
• Selvita
• SGS (SA)
• Shimadzu Corp.
• Thermo Fischer Inc.
• Water Corporation

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year